Arax Advisory Partners’s Ascendis Pharma A/S ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
RCM
ACA
JT
Arax Advisory Partners's ASND Position: Q2 2026 in Review
Arax Advisory Partners increased its Ascendis Pharma A/S (ASND) stake by 1,867% in Q2 2026, buying an estimated $201K and bringing the position to 905 shares worth $241K. The position accounts for ﹤0.01% of the portfolio, ranked #2119.
Arax Advisory Partners first reported a position in ASND in Q2 2025 and has held it in 5 quarters since. 311 funds tracked by Wall St. Rank hold ASND as of Q2 2026.
- Arax Advisory Partners held 905 shares of Ascendis Pharma A/S worth $241K as of Q2 2026.
- Arax Advisory Partners bought 859 Ascendis Pharma A/S shares in Q2 2026, an estimated $201K.
- Ascendis Pharma A/S made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #2119 holding.
- Arax Advisory Partners first reported a position in Ascendis Pharma A/S in Q2 2025 and has held it in 5 quarters since.
- 311 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2026.
Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.